Stockholm, Sweden, 27 August 2026; Inify Laboratories AB (publ.) (the "Company") announces that the following transactions have been completed by close associates of Magne Jordanger, board member and primary insider in Inify:   –          Gallivant S.a.r.l, a company closely associated with board member Magne Jordanger, has sold 47,410,660 shares in Inify at an average price […]

Stockholm, Sweden, 30 January 2026, Reference is made to the stock exchange announcement made by Inify Laboratories AB (publ.) (the “Company“) on 27 January 2026 regarding allocation of new shares to primary insiders in the repair issue announced by the Company on 9 December 2025 (the “Repair Issue“). The number of shares allocated to board […]

Stockholm, Sweden, 27 January 2026; Inify Laboratories AB (publ.) (the “Company“) announces that the below primary insiders were allocated new shares at the subscription price in the repair issue announced by the Company on 9 December 2025 (the “Repair Issue“), as further specified in the attached notification forms:   –          Monsun AS, a company closely […]

Stockholm – 19 December 2025 – Inify Laboratories AB (publ) (the "Company") announces that the below primary insider was allocated new shares at the subscription price in the private placement announced by the Company on 9 December 2025 (the "Private Placement"), as further specified in the attached notification forms: –          Gallivant S.à r.l. and Monsun […]

Stockholm, Sweden, December 16, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Fredrik Palm, CEO and primary insider in Inify, has acquired 12,000 shares in Inify at an average price of NOK 3.383 per share on December 16th. After the transaction, Palm […]

Stockholm, Sweden, August 29, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Martin Ingvar, board member and primary insider in Inify, has acquired 9,500 shares in Inify at an average price of SEK 5.50 per share on August 28th. After the transaction, […]

Stockholm, Sweden, January 30, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Olof Sandén, board member and primary insider in Inify, has acquired 16,840 shares in Inify at an average price of SEK 4.36 per share during January 27th – 29th. After […]

  Stockholm, Sweden, January 24, 2024; Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 23 January 2024, regarding the final results of the subsequent repair offering of shares in the Company (the "Subsequent Offering"). Inify Laboratories AB (publ.) announces that the below primary insiders were allocated new […]

Stockholm, Sweden, December 16, 2024; Inify Laboratories AB (publ.) announces that the below primary insider was allocated new shares at the Offer Price in the Private Placement as further specified in the attached notification forms:   –          Gallivant S.à r.l. and Monsun AS, companies closely associated with board member Magne Jordanger, have been allocated 20,229,274 […]

Stockholm, Sweden, July 5, 2023; Inify Laboratories AB (publ.) has been notified that the following transaction has been completed by a close associate to a primary insider in Inify: Monsun AS, a Norwegian company controlled by Magne Jordanger, board member and primary insider in Inify, has bought 650,000 shares in Inify at an average price […]